Wednesday, 10 April 2024
Xencor, a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen to senior vice president and chief…
Outlet:
CityBiz
Media Type:
Online